Production of adeno-associated viral vectors in insect cells using triple infection: Optimization of baculovirus concentration ratios

被引:39
作者
Aucoin, Marc G.
Perrier, Michel
Kamen, Amine A.
机构
[1] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
[2] Univ Montreal, Ecole Polytech, Montreal, PQ, Canada
关键词
multiplicity of infection; time of infection; baculovirus; insect cells; adeno-associated virus;
D O I
10.1002/bit.21069
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The production of viral vectors or virus-like particles for gene therapy or vaccinations using the baculovirus expression system is gaining in popularity. Recently, reports of a viral vector based on adeno-associated virus (AAV) produced in insect cells using the baculovirus expression vector system have been published. This system requires the triple infection of cells with baculovirus vectors containing the AAV gene for replication proteins (BacRep), the AAV gene for structural proteins (BacCap), and the AAV vector genome (BacITR). A statistical approach was used to investigate the multiplicities of infection of the three baculoviruses and the results were extended to the production of AAVs containing various transgenes. Highest AAV yields were obtained when BacRep and BacCap, the baculovirus vectors containing genes that code for proteins necessary for the formation of the AAV vector, were added in equal amounts at high multiplicities of infection. These combinations also resulted in the closest ratios of infectious to total AAV particles produced. Overexpression of the AAV structural proteins led to the production of empty AAV capsids, which is believed to overload the cellular machinery, preventing proper encapsidation of the AAV vector transgene, and decreased the viability of the insect cells. Delaying the input of BacCap, to reduce the amount of capsids produced, resulted in lower infectious AAV titers then when all three baculoviruses were put into the system at the same time. The amount of BacITR added to the system can be less than the other two without loss of AAV yield. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:1081 / 1092
页数:12
相关论文
共 42 条
[1]   MUTAGENESIS OF AN AUG CODON IN THE ADENO-ASSOCIATED VIRUS REP GENE - EFFECTS ON VIRAL-DNA REPLICATION [J].
CHEJANOVSKY, N ;
CARTER, BJ .
VIROLOGY, 1989, 173 (01) :120-128
[2]   A catalog of dermatology utilities: A measure of the burden of skin diseases [J].
Chen, SC ;
Bayoumi, AM ;
Soon, SL ;
Aftergut, K ;
Cruz, P ;
Sexton, SA ;
McCall, CO ;
Goldstein, MK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (02) :160-168
[3]   Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5 [J].
DiMattia, M ;
Govindasamy, L ;
Levy, HC ;
Gurda-Whitaker, B ;
Kalina, A ;
Kohlbrenner, E ;
Chiorini, JA ;
McKenna, R ;
Muzyczka, N ;
Zolotukhin, S ;
Agbandje-Mckenna, M .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2005, 61 :917-921
[4]   Novel tools for production and purification of recombinant adenoassociated virus vectors [J].
Grimm, D ;
Kern, A ;
Rittner, K ;
Kleinschmidt, JA .
HUMAN GENE THERAPY, 1998, 9 (18) :2745-2760
[5]   Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2 [J].
Grimm, D ;
Kern, A ;
Pawlita, M ;
Ferrari, FK ;
Samulski, RJ ;
Kleinschmidt, JA .
GENE THERAPY, 1999, 6 (07) :1322-1330
[6]  
Haas R, 2004, THESIS U QUEENSLAND
[7]  
HOLSCHER C, 1995, J VIROL, V69, P6880
[8]   Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells [J].
Hu, YC ;
Hsu, JTA ;
Huang, JH ;
Ho, MS ;
Ho, YC .
BIOTECHNOLOGY LETTERS, 2003, 25 (12) :919-925
[9]   Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: Deterministic predictions and experimental results [J].
Hu, YC ;
Bentley, WE .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 75 (01) :104-119
[10]  
Jiang BM, 1998, BIOTECHNOL BIOENG, V60, P369, DOI 10.1002/(SICI)1097-0290(19981105)60:3<369::AID-BIT14>3.0.CO